tirzepatide gotas Flex-Dose 1 mL Injectable 10 mg/mL Tirzepatide Flex-Dose 3 mL Injectable
Description
As of 2026, neither compound has FDA approval, limiting prescribing to research contexts or off-label use by physicians specializing in obesity medicine or endocrinology
Kim SH, Abbasi F, Lamendola C, Liu A, Ariel D, Schaaf P, et al
For document-review context, use the COA evaluation guide before comparing this listing with any future product-level records
The discovery of this drug was a real breakthrough in medicine and pharmacology, it helps effectively combat excess weight and is effective in the treatment of diabetes
